← Drug Safety Associate — Pharmacovigilance (CRO / Pharma MNC)
publisheddomain

Pharmacovigilance case processing

Process an Individual Case Safety Report the way an entry-level Drug Safety Associate does: confirm a report is a valid case, classify seriousness and expectedness, set Day 0 and the reporting clock, extract source information into structured case fields, assess causality with the Naranjo algorithm and the WHO-UMC system, write a chronological case narrative and recognise what a CIOMS-I form carries. It teaches the case-processing method that every safety database encodes; it is not Oracle Argus, ARISg or MedDRA software training.

What you will be able to answer

A hospital pharmacist emails your PV team: a 58-year-old man started a new antibiotic, developed a widespread rash and swelling of the lips on day 4, was admitted overnight, and recovered after the drug was stopped. The email gives his initials and age but no batch number, and mentions he also takes amlodipine. What can you produce before the case goes to medical review?

A processed case: a validity check against the four minimum elements with Day 0 recorded; a seriousness classification with the criterion that applies; an expectedness call stated against the named reference safety information; the resulting reporting clock; the source information placed into patient, reporter, suspect and concomitant drug, event, treatment and outcome fields with dechallenge recorded; a Naranjo score and a WHO-UMC category with the reasoning behind each; a chronological case narrative; and a list of follow-up questions for the reporter — without claiming a final medical causality judgment or inventing local regulatory deadlines.

Concepts
10
Selected clips
41m 43s
Employers use it
12

One payment

₹99

The videos are free

This is what you pay for

Compared → kept
35 → 10
Full videos → selected
2h 49m → 41m 43s
Concepts
10

Course outline

Learn from selected clips, concept by concept

Concept 1

Follow one adverse-event report from intake to submission

free

Concept 1 · Follow one adverse-event report from intake to submission

0:00 / 0:26

Concept 2

Decide whether a report is a valid case

locked

After: pv-case-lifecycle

Before anything else, a case processor asks one question of every report: is there enough here to call it a case?

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 34s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 3

Classify seriousness with the six criteria

locked

After: valid-icsr-minimum-criteria

A crushing headache can be severe without being serious — and the difference decides how fast the case must move.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 30s kept
Video review
5 compared

Video title and channel appear once unlocked.

Concept 4

Judge expectedness against the reference safety information

locked

After: seriousness-criteria

'Unexpected' doesn't mean surprising — it means the event isn't described that way in the document the company is held to.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
47s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 5

Set Day 0 and the reporting clock

locked

After: expectedness-reference-safety-information

The reporting deadline starts the moment the company first holds a valid case — not when it reaches your desk.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 52s kept
Video review
4 compared

Video title and channel appear once unlocked.

Concept 6

Extract source information into structured case fields

locked

After: valid-icsr-minimum-criteria

A safety database is only as good as the person reading the source: every field is a decision about what the reporter actually said.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
3m 40s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 7

Score causality with the Naranjo algorithm

locked

After: case-data-entry

Ten questions, each worth points, turn 'did the drug cause this?' into a score you can defend.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
3m 32s kept
Video review
5 compared

Video title and channel appear once unlocked.

Concept 8

Assign a WHO-UMC causality category

locked

After: naranjo-algorithm

WHO-UMC asks the same question as Naranjo without a score — and the two methods don't always agree.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
7m 52s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 9

Write a chronological case narrative

locked

After: case-data-entry, who-umc-causality

A reviewer who never sees the source should be able to read your narrative and reach the same conclusion you did.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
10m 55s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 10

Read and complete a CIOMS-I form

locked

After: icsr-narrative-writing

The processed case often leaves the building as a one-page form — and every field on it traces back to work you've already done.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
7m 42s kept
Video review
3 compared

Video title and channel appear once unlocked.

Selection criteria

  • Works through an adverse-event case or report rather than defining pharmacovigilance in the abstract
  • Applies ICH E2A / E2D concepts to a decision a case processor actually makes
  • Shows the reasoning behind a classification, score or narrative choice, not only the answer
  • Distinguishes the case processor's assessment from the medical reviewer's final judgment and from local regulatory requirements
  • Avoids software-only button-clicking, certificate-course marketing and exam-style definition lists

What was rejected

20 candidates did not meet the course criteria.

  • Only recites the four elements as a list with no example
  • Only recites the four elements as a list with no example
  • The video ends abruptly right as the topic of seriousness criteria is introduced, without actually enumerating or applying them.
  • Does not discuss the ICH seriousness criteria or serious adverse events.
  • discusses only adverse-event grading scales such as CTCAE
  • lists the criteria with no example classification
  • The video focuses on introductory regulatory history and the WHO, never covering expectedness or reference safety information.
  • Lacks discussion of specific expedited reporting timeframes (7/15 days based on seriousness/expectedness) and contains no numerical worked example.
  • States timelines without explaining what starts the clock
  • States timelines without explaining what starts the clock
  • Video cuts off before covering product tabs, event details, medical history, or lab assessments.
  • Only clicks through a safety-database screen without explaining what each field captures or where it came from in the source
  • Does not discuss the Naranjo algorithm or causality assessment; focuses entirely on the ABCDEF classification of adverse drug reactions.
  • Only lists the questions or bands without scoring a case
  • Only lists the questions or bands without scoring a case
  • Only lists the questions or bands without scoring a case
  • only describes what a narrative is without showing one
  • is about clinical study report or aggregate report writing; or only describes what a narrative is without showing one
  • The video mainly focuses on CIOMS organizational history and working groups; the form is only shown briefly at the end without a full section walk-through or worked case example.
  • Mentions CIOMS only as an organisation without showing the form

Where this skill is used

Drug Safety Associate — Pharmacovigilance (CRO / Pharma MNC)

The single most common corporate landing spot for Pharm.D freshers in India. You process Individual Case Safety Reports (ICSRs) — extracting adverse-event data, assessing causality, coding with MedDRA, and writing safety narratives — inside CROs and IT-pharma units (TCS, Cognizant, Accenture, IQVIA). Your clinical training gives a genuine edge in causality assessment and narrative writing over B.Pharm competitors. Progression runs from case processing to aggregate reports (PSURs/PBRERs) to signal detection and PV management.

12 mapped employers

Explore path →